Patent Assignment
Reel/Frame 053301/0113
Assignment of Assignor's Interest
Recorded: 2020-07-24
Pages: 8
Assignor
ASTEX PHARMACEUTICALS, INC.
Executed: 2012-07-16
Assignee
TOLERO PHARMACEUTICALS, INC.
3900 N. TRAVERSE MOUNTAIN BLVD., LEHI, UTAH, 84043
Covered Properties
(3)
Pyrimidine-2,4-Diamine Derivatives and Their Use as JAK2 Kinase Inhibitors
Application:
60/892,385 →
Pyrimidine-2,4-Diamine Derivatives and Their Use as JAK2 Kinase Inhibitors
Application:
60/911,776 →
Axl Kinase Inhibitors
Application:
60/911,832 →
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 17, 2007
From: BEARSS, DAVID J.; LIU, XIAO-HUI; VANKAYALAPATI, HARIPRASAD
To: SUPERGEN, INC.
Reel/Frame 019169/0031 →
Assignment of Assignor's Interest
Apr 25, 2007
From: BEARSS, DAVID J.; VANKAYALAPATI, HARIPRASAD; XU, YONG
To: SUPERGEN, INC.
Reel/Frame 019211/0413 →
Assignment of Assignor's Interest
Mar 13, 2008
From: BEARSS, DAVID J.; LIU, XIAO-HUI; VANKAYALAPATI, HARIPRASAD
To: SUPERGEN, INC.
Reel/Frame 020648/0486 →
Security Interest
Nov 17, 2016
From: TOLERO PHARMACEUTICALS, INC.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 040362/0884 →
Merger
Jul 24, 2020
From: SUPERGEN, INC.
To: ASTEX PHARMACEUTICALS, INC.
Reel/Frame 053300/0930 →
Change of Name
Jul 28, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053325/0735 →
Merger
Jul 28, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 053325/0542 →